Showing 2,501 - 2,520 results of 2,524 for search '"Europe"', query time: 0.07s Refine Results
  1. 2501

    QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis by Christian Labenz, Simon J. Gairing, Leonard Kaps, Alena F. Ehrenbauer, Eva M. Schleicher, Sophie Mengel, Julius F.M. Egge, Maria M. Gabriel, Peter R. Galle, Heiner Wedemeyer, Alexander Zipprich, Cristina Ripoll, Robin Greinert, Benjamin Maasoumy

    Published 2025-03-01
    “…At present, there are no data on its clinical utility for MHE screening in patients in Europe, and only limited data are available regarding its comparison to the Animal Naming Test (ANT). …”
    Get full text
    Article
  2. 2502
  3. 2503

    The impact of pre-transplant ventricular assist device support in pediatric patients with end-stage heart failure on the outcomes of heart transplantation—“a single center experien... by L. Lily Rosenthal, L. Lily Rosenthal, L. Lily Rosenthal, Carola Grinninger, Sarah Marie Ulrich, Robert Dalla Pozza, Nikolaus A. Haas, Paolo Brenner, Michael Schmoeckel, Sebastian Michel, Sebastian Michel, Sebastian Michel, Christian Hagl, Christian Hagl, Jürgen Hörer, Jürgen Hörer, Jürgen Hörer

    Published 2025-01-01
    “…In light of the limited availability of donor organs, particularly in Europe, the number of children requiring ventricular assist device support is rising at an unavoidable rate.MethodsWe performed a retrospective cohort study of patients who underwent a single and primary pediatric heart transplantation. …”
    Get full text
    Article
  4. 2504
  5. 2505

    Investigating the Effect of Chicken Manure and Potassium Sulfate on the Physiological Properties of Fenugreek )Trigonella foenum-graecum L.( Medicinal Plant by Mohammad hossein Aminifard, Sajjad Nadafa, Hassan Hassan, Mehdi Jahani

    Published 2025-12-01
    “….), is an annual plant found in many countries in Africa, Asia, and Europe, and India is the largest producer in the world. …”
    Get full text
    Article
  6. 2506

    MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy by Michael Thomas, Petros Christopoulos, Wade T Iams, Julien Mazieres, Alexis B Cortot, Nir Peled, Gabriele Minuti, Egbert F Smit, Francois Audhuy, Karin Berghoff, S Peter Eggleton, Frank Fries, Maike Hildenbrand, Peter Liu, Seyed Hamidreza Mahmoudpour, Christoph Menzel, Dina Oksen

    Published 2025-01-01
    “…Registry site inclusion is dependent on confirmation that local METex14 skipping detectionmethods are sufficient to confirm METex14 skipping status.MOMENT is currently active at more than 60 sites across Europe and North America and approximately 700 patients are expected to be enrolled within the next 4 years. …”
    Article
  7. 2507

    Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the... by Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite, Salima Hateb, Janet Addison, the PERFUSE investigators

    Published 2024-10-01
    “…Abstract Background There is a need for published data on real-world use of SB5, an adalimumab (ADL) biosimilar approved in Europe in 2017, on the basis of evidence from pre-clinical and analytic data as well as phase I and III clinical studies demonstrating equivalent efficacy and comparable pharmacokinetics, safety and immunogenicity profiles as the reference ADL. …”
    Get full text
    Article
  8. 2508

    Is maternal diabetes during pregnancy associated with neurodevelopmental, cognitive and behavioural outcomes in children? Insights from individual participant data meta-analysis in... by Rachelle A. Pretorius, Demetris Avraam, Mònica Guxens, Jordi Julvez, Jennifer R. Harris, Johanna Thorbjornsrud Nader, Tim Cadman, Ahmed Elhakeem, Katrine Strandberg-Larsen, Hanan El Marroun, Serena Defina, Tiffany C. Yang, Rosie McEachan, John Wright, Jesús Ibarluzea, Loreto Santa-Marina, Juana Mari Delgado, Marisa Rebagliato, Marie-Aline Charles, Chloe Vainqueur, Silvia Maritano, Daniela Zugna, Wen Lun Yuan, Barbara Heude, Rae-Chi Huang

    Published 2025-01-01
    “…Methods Harmonised data from > 200 000 mother-child pairs across ten birth cohorts in Europe and Australia were available. Mother-child pairs were included for analysis to determine whether GDM was recorded (yes or no) and whether at least one neurodevelopmental, cognitive and behavioural outcome was available in children aged 3 to 13 years. …”
    Get full text
    Article
  9. 2509

    Excess costs of post-traumatic stress disorder related to child maltreatment in Germany by Thomas Grochtdreis, Hans-Helmut König, Falk Leichsenring, Manfred E. Beutel, Lila Feix, Harald Gündel, Andrea Hermann, Melissa Hitzler, Christine Knaevelsrud, Iris-Tatjana Kolassa, Johannes Kruse, Helen Niemeyer, Fatima Nöske, Simone Salzer, Karoline Sophie Sauer, Patrick Schuster, Christiane Steinert, Kerstin Weidner, Jörn von Wietersheim, Jürgen Hoyer, Judith Dams

    Published 2025-01-01
    “…Abstract Background Childhood maltreatment (CM) significantly increases the risk of developing post-traumatic stress disorder (PTSD) for which the prevalence in Europe is higher than initially assumed. While the high economic burden of PTSD is well-documented, little is known about the health care cost differences between individuals with PTSD-CM and those without PTSD in Germany. …”
    Get full text
    Article
  10. 2510

    Antimicrobial resistance (AMR) and spread of New Delhi Metallo-β-Lactamase (NDM) in Italy: A call for policymakers by Gabriella Nucera

    Published 2019-11-01
    “…The levels of carbapenem-resistant Enterobacteriaceae (CRE) and Acinetobacter baumannii have now reached hyper-endemic levels and, together with meticillin-resistant Staphylococcus aureus (MRSA), this situation causes Italy to be one of the Member States with the highest level of resistance in Europe [5, 6]. Recently, a large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy, where 9 Tuscan hospitals notified, from 1 November 2018 to 23 May 2019, a total of 350 cases, including those related to asymptomatic carriers. …”
    Article
  11. 2511
  12. 2512

    Treatment Inertia and Symptom Burden in Anemia of CKD: Insights from the SATISFY Survey in the Middle East, South Africa, and Türkiye by Arici M, Al-Ghamdi SMG, Assounga AG, El-Koraie AF, McMillan A, Camidge LJ, Sumarsono B, Blogg M, Ng DB, Lansang EP

    Published 2025-01-01
    “…Ltd, Singapore, Singapore; 7Astellas Pharma Europe Ltd, Addlestone, UKCorrespondence: Mustafa Arici, Hacettepe University Faculty of Medicine, Department of Nephrology, Sihhiye, Ankara, 06100, Türkiye, Tel +90-312-324 3109, Fax +90-312-311 3958, Email marici@hacettepe.edu.tr, aricim@gmail.comIntroduction: Limited data exist regarding treatment patterns and symptom burden of patients with anemia of chronic kidney disease (CKD) in the Middle East, South Africa, and Türkiye.Methods: This real-world study explored clinical characteristics, symptom burden, and treatment patterns of patients with anemia of CKD living in the Middle East, South Africa, and Türkiye. …”
    Get full text
    Article
  13. 2513
  14. 2514

    La flore sauvage du boulevard Dr Henri-Henrot à Reims/Durocortorum : approche carpologique de l’environnement du site et des productions de denrées végétales by Véronique Matterne, Clémence Pagnoux

    Published 2022-11-01
    “…These plants, which are transgressive in their original environments, do not exist naturally in the wild within western Europe; their survival depends on the domestic species they accompany (Jauzein 1995, p. 12). …”
    Get full text
    Article
  15. 2515

    Editorial by Pieter Vanhuysse, Antony Mason, Jörg Tremmel, Markus Rutsche, Maria Lenk

    Published 2018-01-01
    “…Thus the key message from Gál’s earlier work is corroborated: Europe is a continent of “pro-elderly welfare states within child-oriented societies.”[4] This highlights an important further conclusion we can draw from this special issue. …”
    Get full text
    Article
  16. 2516

    Contribution à l’histoire de la boulangerie romaine : étude de « pains/galettes » découverts en Gaule by Andreas G. Heiss, Véronique Matterne, Nicolas Monteix, Margaux Tillier, Camille Noûs

    Published 2021-12-01
    “…These findings differ from the Metal Age specimens previously studied in Europe, which appear to contain a higher frequency of bran and glume remains. …”
    Get full text
    Article
  17. 2517

    IGJR 1/2020: Housing crisis: How can we improve the situation for young people? by IF and FRFG

    Published 2018-12-01
    “…Younger generations, on the other hand, are disadvantaged in two respects: today’s increased demand leads to further pressure on the housing market in the low-price segment, which in turn leads to an increase in the rent burden for lower and middle income groups, and also makes the purchase of residential property more difficult. In many parts of Europe, such as the Southeast of the UK, in the 1980s the average cost of a first home was three to four times the annual average salary; today it can be ten or twelve times the annual average salary. …”
    Get full text
    Article
  18. 2518

    IGJR 1/2020: Housing crisis: How can we improve the situation for young people? by IF and FRFG

    Published 2019-07-01
    “…Younger generations, on the other hand, are disadvantaged in two respects: today’s increased demand leads to further pressure on the housing market in the low-price segment, which in turn leads to an increase in the rent burden for lower and middle income groups, and also makes the purchase of residential property more difficult. In many parts of Europe, such as the Southeast of the UK, in the 1980s the average cost of a first home was three to four times the annual average salary; today it can be ten or twelve times the annual average salary. …”
    Get full text
    Article
  19. 2519

    Changes in laboratory value improvement and mortality rates over the course of the pandemic: an international retrospective cohort study of hospitalised patients infected with SARS... by Ramakanth Kavuluru, Xuan Wang, Paul Avillach, Florence Bourgeois, Kee Yuan Ngiam, Gabriel A Brat, Isaac Kohane, Tianxi Cai, Yuk-Lam Ho, Yuan Luo, Harrison G Zhang, Kelly Cho, Vincent Benoit, Antoine Neuraz, Chuan Hong, Sehi L'Yi, Griffin Weber, Bryce W Q Tan, Alba Gutiérrez-Sacristán, Clara-Lea Bonzel, Nathan P Palmer, Alberto Malovini, Valentina Tibollo, Meghan R Hutch, Molei Liu, Riccardo Bellazzi, Luca Chiovato, Fernando J Sanz Vidorreta, Trang T Le, William Yuan, Bertrand Moal, Michele Morris, David A Hanauer, Sarah Maidlow, Kavishwar Wagholikar, Shawn Murphy, Hossein Estiri, Adeline Makoudjou, Patric Tippmann, Jeffery Klann, Robert W Follett, Nils Gehlenborg, Gilbert S Omenn, Zongqi Xia, Arianna Dagliati, Shyam Visweswaran, Lav P Patel, Danielle L Mowery, Emily R Schriver, Malarkodi Jebathilagam Samayamuthu, Sara Lozano-Zahonero, Daniela Zöller, Amelia L M Tan, Byorn W L Tan, John H Holmes, Petra Schubert, Brett K. Beaulieu-Jones, Miguel Pedrera-Jiménez, Noelia García-Barrio, Pablo Serrano-Balazote, Andrew South

    Published 2022-06-01
    “…Objective To assess changes in international mortality rates and laboratory recovery rates during hospitalisation for patients hospitalised with SARS-CoV-2 between the first wave (1 March to 30 June 2020) and the second wave (1 July 2020 to 31 January 2021) of the COVID-19 pandemic.Design, setting and participants This is a retrospective cohort study of 83 178 hospitalised patients admitted between 7 days before or 14 days after PCR-confirmed SARS-CoV-2 infection within the Consortium for Clinical Characterization of COVID-19 by Electronic Health Record, an international multihealthcare system collaborative of 288 hospitals in the USA and Europe. The laboratory recovery rates and mortality rates over time were compared between the two waves of the pandemic.Primary and secondary outcome measures The primary outcome was all-cause mortality rate within 28 days after hospitalisation stratified by predicted low, medium and high mortality risk at baseline. …”
    Get full text
    Article
  20. 2520

    COVID-19 – if the cure is worse than the disease. The Italian chaos by Giuseppe FERRARI

    Published 2020-03-01
    “…In addition, we have the Lombardy case, one of the most important economy in Europe. Why in this region number of deceased and infected people are not even comparable with those in other parts of the world? …”
    Article